APO Research
Talk to an analyst

APO RESEARCH · REPORT

Menopausal Hot Flashes Drugs

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Menopausal Hot Flashes Drugs Market Outlook and Growth Opportunities 2026

20 December 2025190 pages

Choose your research edition.

Industry ResearchMenopausal Hot Flashes Drugs Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Menopausal Hot Flashes Drugs Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Menopausal Hot Flashes Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Menopausal Hot Flashes Drugs Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Menopausal Hot Flashes Drugs Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Menopausal Hot Flashes Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Menopausal Hot Flashes Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Menopausal Hot Flashes Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Menopausal Hot Flashes Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Menopausal Hot Flashes Drugs market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Menopausal Hot Flashes Drugs market include Novartis, Pfizer, Bayer, Novo Nordisk, iHealth Labs, Hisamitsu Pharmaceutical and Allergan, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Menopausal Hot Flashes Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Menopausal Hot Flashes Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Menopausal Hot Flashes Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Menopausal Hot Flashes Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Menopausal Hot Flashes Drugs Segment by Company

Novartis

Pfizer

Bayer

Novo Nordisk

iHealth Labs

Hisamitsu Pharmaceutical

Allergan

Menopausal Hot Flashes Drugs Segment by Type

Pill Menopausal Hot Flashes Drugs

Oral Liquid Menopausal Hot Flashes Drugs

Other

Menopausal Hot Flashes Drugs Segment by Application

Retail Outlets

Online Stores

Menopausal Hot Flashes Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Menopausal Hot Flashes Drugs status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Menopausal Hot Flashes Drugs market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Menopausal Hot Flashes Drugs significant trends, drivers, influence factors in global and regions.

6. To analyze Menopausal Hot Flashes Drugs competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Menopausal Hot Flashes Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Menopausal Hot Flashes Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Menopausal Hot Flashes Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Menopausal Hot Flashes Drugs market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Menopausal Hot Flashes Drugs industry.

Chapter 3: Detailed analysis of Menopausal Hot Flashes Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Menopausal Hot Flashes Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Menopausal Hot Flashes Drugs in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Menopausal Hot Flashes Drugs Industry Trends Table 2. Menopausal Hot Flashes Drugs Industry Drivers Table 3. Menopausal Hot Flashes Drugs Industry Opportunities and Challenges Table 4. Menopausal Hot Flashes Drugs Industry Restraints Table 5. Global Menopausal Hot Flashes Drugs Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Menopausal Hot Flashes Drugs Revenue Share by Company (2021-2026) Table 7. Global Menopausal Hot Flashes Drugs Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Menopausal Hot Flashes Drugs Sales Volume Share by Company (2021-2026) Table 9. Global Menopausal Hot Flashes Drugs Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Menopausal Hot Flashes Drugs Company Ranking, (2024-2026) & (USD Million) Table 11. Global Menopausal Hot Flashes Drugs Key Company Manufacturing Base & Headquarters Table 12. Global Menopausal Hot Flashes Drugs Company, Product Type & Application Table 13. Global Menopausal Hot Flashes Drugs Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Menopausal Hot Flashes Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Pill Menopausal Hot Flashes Drugs Table 18. Significant Companies of Oral Liquid Menopausal Hot Flashes Drugs Table 19. Significant Companies of Other Table 20. Global Menopausal Hot Flashes Drugs Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Menopausal Hot Flashes Drugs Sales Volume by Type (2021-2026) & (K Units) Table 22. Global Menopausal Hot Flashes Drugs Sales Volume by Type (2027-2032) & (K Units) Table 23. Global Menopausal Hot Flashes Drugs Sales Volume Share by Type (2021-2026) Table 24. Global Menopausal Hot Flashes Drugs Sales Volume Share by Type (2027-2032) Table 25. Global Menopausal Hot Flashes Drugs Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Menopausal Hot Flashes Drugs Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Menopausal Hot Flashes Drugs Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Menopausal Hot Flashes Drugs Sales Value Share by Type (2021-2026) Table 29. Global Menopausal Hot Flashes Drugs Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Retail Outlets Table 31. Significant Companies of Online Stores Table 32. Global Menopausal Hot Flashes Drugs Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Menopausal Hot Flashes Drugs Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Menopausal Hot Flashes Drugs Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Menopausal Hot Flashes Drugs Sales Volume Share by Application (2021-2026) Table 36. Global Menopausal Hot Flashes Drugs Sales Volume Share by Application (2027-2032) Table 37. Global Menopausal Hot Flashes Drugs Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Menopausal Hot Flashes Drugs Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Menopausal Hot Flashes Drugs Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Menopausal Hot Flashes Drugs Sales Value Share by Application (2021-2026) Table 41. Global Menopausal Hot Flashes Drugs Sales Value Share by Application (2027-2032) Table 42. Global Menopausal Hot Flashes Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Menopausal Hot Flashes Drugs Sales by Region (2021-2026) & (K Units) Table 44. Global Menopausal Hot Flashes Drugs Sales Market Share by Region (2021-2026) Table 45. Global Menopausal Hot Flashes Drugs Sales by Region (2027-2032) & (K Units) Table 46. Global Menopausal Hot Flashes Drugs Sales Market Share by Region (2027-2032) Table 47. Global Menopausal Hot Flashes Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Menopausal Hot Flashes Drugs Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Menopausal Hot Flashes Drugs Sales Value Share by Region (2021-2026) Table 50. Global Menopausal Hot Flashes Drugs Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Menopausal Hot Flashes Drugs Sales Value Share by Region (2027-2032) Table 52. Global Menopausal Hot Flashes Drugs Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Menopausal Hot Flashes Drugs Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Menopausal Hot Flashes Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Menopausal Hot Flashes Drugs Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Menopausal Hot Flashes Drugs Sales by Country (2021-2026) & (K Units) Table 57. Global Menopausal Hot Flashes Drugs Sales Market Share by Country (2021-2026) Table 58. Global Menopausal Hot Flashes Drugs Sales by Country (2027-2032) & (K Units) Table 59. Global Menopausal Hot Flashes Drugs Sales Market Share by Country (2027-2032) Table 60. Global Menopausal Hot Flashes Drugs Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Menopausal Hot Flashes Drugs Sales Value Market Share by Country (2021-2026) Table 62. Global Menopausal Hot Flashes Drugs Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Menopausal Hot Flashes Drugs Sales Value Market Share by Country (2027-2032) Table 64. Novartis Company Information Table 65. Novartis Business Overview Table 66. Novartis Menopausal Hot Flashes Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Novartis Menopausal Hot Flashes Drugs Product Portfolio Table 68. Novartis Recent Development Table 69. Pfizer Company Information Table 70. Pfizer Business Overview Table 71. Pfizer Menopausal Hot Flashes Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Pfizer Menopausal Hot Flashes Drugs Product Portfolio Table 73. Pfizer Recent Development Table 74. Bayer Company Information Table 75. Bayer Business Overview Table 76. Bayer Menopausal Hot Flashes Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Bayer Menopausal Hot Flashes Drugs Product Portfolio Table 78. Bayer Recent Development Table 79. Novo Nordisk Company Information Table 80. Novo Nordisk Business Overview Table 81. Novo Nordisk Menopausal Hot Flashes Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Novo Nordisk Menopausal Hot Flashes Drugs Product Portfolio Table 83. Novo Nordisk Recent Development Table 84. iHealth Labs Company Information Table 85. iHealth Labs Business Overview Table 86. iHealth Labs Menopausal Hot Flashes Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. iHealth Labs Menopausal Hot Flashes Drugs Product Portfolio Table 88. iHealth Labs Recent Development Table 89. Hisamitsu Pharmaceutical Company Information Table 90. Hisamitsu Pharmaceutical Business Overview Table 91. Hisamitsu Pharmaceutical Menopausal Hot Flashes Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Hisamitsu Pharmaceutical Menopausal Hot Flashes Drugs Product Portfolio Table 93. Hisamitsu Pharmaceutical Recent Development Table 94. Allergan Company Information Table 95. Allergan Business Overview Table 96. Allergan Menopausal Hot Flashes Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Allergan Menopausal Hot Flashes Drugs Product Portfolio Table 98. Allergan Recent Development Table 99. Key Raw Materials Table 100. Raw Materials Key Suppliers Table 101. Menopausal Hot Flashes Drugs Distributors List Table 102. Menopausal Hot Flashes Drugs Customers List Table 103. Research Programs/Design for This Report Table 104. Authors List of This Report Table 105. Secondary Sources Table 106. Primary Sources List of Figures Figure 1. Menopausal Hot Flashes Drugs Product Image Figure 2. Global Menopausal Hot Flashes Drugs Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Menopausal Hot Flashes Drugs Sales Value (2021-2032) & (US$ Million) Figure 4. Global Menopausal Hot Flashes Drugs Sales (2021-2032) & (K Units) Figure 5. Global Menopausal Hot Flashes Drugs Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Menopausal Hot Flashes Drugs Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Pill Menopausal Hot Flashes Drugs Image Figure 10. Oral Liquid Menopausal Hot Flashes Drugs Image Figure 11. Other Image Figure 12. Global Menopausal Hot Flashes Drugs Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Menopausal Hot Flashes Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Menopausal Hot Flashes Drugs Sales Volume Share by Type (2021-2032) Figure 15. Global Menopausal Hot Flashes Drugs Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Menopausal Hot Flashes Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Menopausal Hot Flashes Drugs Sales Value Share by Type (2021-2032) Figure 18. Retail Outlets Image Figure 19. Online Stores Image Figure 20. Global Menopausal Hot Flashes Drugs Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Menopausal Hot Flashes Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Menopausal Hot Flashes Drugs Sales Volume Share by Application (2021-2032) Figure 23. Global Menopausal Hot Flashes Drugs Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Menopausal Hot Flashes Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Menopausal Hot Flashes Drugs Sales Value Share by Application (2021-2032) Figure 26. Global Menopausal Hot Flashes Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Menopausal Hot Flashes Drugs Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Menopausal Hot Flashes Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Menopausal Hot Flashes Drugs Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Menopausal Hot Flashes Drugs Sales Value (2021-2032) & (US$ Million) Figure 31. North America Menopausal Hot Flashes Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Menopausal Hot Flashes Drugs Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Menopausal Hot Flashes Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Menopausal Hot Flashes Drugs Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Menopausal Hot Flashes Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Menopausal Hot Flashes Drugs Sales Value (2021-2032) & (US$ Million) Figure 37. South America Menopausal Hot Flashes Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Menopausal Hot Flashes Drugs Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Menopausal Hot Flashes Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Menopausal Hot Flashes Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Menopausal Hot Flashes Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Menopausal Hot Flashes Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Menopausal Hot Flashes Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Menopausal Hot Flashes Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Menopausal Hot Flashes Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Menopausal Hot Flashes Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Menopausal Hot Flashes Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Menopausal Hot Flashes Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Menopausal Hot Flashes Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Menopausal Hot Flashes Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Menopausal Hot Flashes Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Menopausal Hot Flashes Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Menopausal Hot Flashes Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Menopausal Hot Flashes Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Menopausal Hot Flashes Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Menopausal Hot Flashes Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Menopausal Hot Flashes Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Menopausal Hot Flashes Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Menopausal Hot Flashes Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Menopausal Hot Flashes Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Menopausal Hot Flashes Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Menopausal Hot Flashes Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Menopausal Hot Flashes Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Menopausal Hot Flashes Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Menopausal Hot Flashes Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Menopausal Hot Flashes Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Menopausal Hot Flashes Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Menopausal Hot Flashes Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Menopausal Hot Flashes Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Menopausal Hot Flashes Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Menopausal Hot Flashes Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Menopausal Hot Flashes Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Menopausal Hot Flashes Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Menopausal Hot Flashes Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Menopausal Hot Flashes Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Menopausal Hot Flashes Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Menopausal Hot Flashes Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Menopausal Hot Flashes Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Menopausal Hot Flashes Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Menopausal Hot Flashes Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Menopausal Hot Flashes Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Menopausal Hot Flashes Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Menopausal Hot Flashes Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Menopausal Hot Flashes Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Menopausal Hot Flashes Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Menopausal Hot Flashes Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Menopausal Hot Flashes Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Menopausal Hot Flashes Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Menopausal Hot Flashes Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Menopausal Hot Flashes Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Menopausal Hot Flashes Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Menopausal Hot Flashes Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Menopausal Hot Flashes Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Menopausal Hot Flashes Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Menopausal Hot Flashes Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Menopausal Hot Flashes Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Menopausal Hot Flashes Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Menopausal Hot Flashes Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Menopausal Hot Flashes Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Menopausal Hot Flashes Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Menopausal Hot Flashes Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Menopausal Hot Flashes Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Menopausal Hot Flashes Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Menopausal Hot Flashes Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Menopausal Hot Flashes Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Menopausal Hot Flashes Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Menopausal Hot Flashes Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Menopausal Hot Flashes Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Menopausal Hot Flashes Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Menopausal Hot Flashes Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Menopausal Hot Flashes Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Menopausal Hot Flashes Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Menopausal Hot Flashes Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Menopausal Hot Flashes Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Menopausal Hot Flashes Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Menopausal Hot Flashes Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Menopausal Hot Flashes Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Menopausal Hot Flashes Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Menopausal Hot Flashes Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Menopausal Hot Flashes Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Menopausal Hot Flashes Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Menopausal Hot Flashes Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Menopausal Hot Flashes Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Menopausal Hot Flashes Drugs Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Menopausal Hot Flashes Drugs Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Pill Menopausal Hot Flashes Drugs
  • Oral Liquid Menopausal Hot Flashes Drugs
  • Other
Applications
  • Retail Outlets
  • Online Stores
Companies covered
  • Novartis
  • Pfizer
  • Bayer
  • Novo Nordisk
  • iHealth Labs
  • Hisamitsu Pharmaceutical
  • Allergan

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Menopausal Hot Flashes Drugs Sales Value (2021-2032)
  4. 1.2.2 Global Menopausal Hot Flashes Drugs Sales Volume (2021-2032)
  5. 1.2.3 Global Menopausal Hot Flashes Drugs Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Menopausal Hot Flashes Drugs Market Dynamics
  1. 2.1 Menopausal Hot Flashes Drugs Industry Trends
  2. 2.2 Menopausal Hot Flashes Drugs Industry Drivers
  3. 2.3 Menopausal Hot Flashes Drugs Industry Opportunities and Challenges
  4. 2.4 Menopausal Hot Flashes Drugs Industry Restraints
3 Menopausal Hot Flashes Drugs Market by Company
  1. 3.1 Global Menopausal Hot Flashes Drugs Company Revenue Ranking in 2025
  2. 3.2 Global Menopausal Hot Flashes Drugs Revenue by Company (2021-2026)
  3. 3.3 Global Menopausal Hot Flashes Drugs Sales Volume by Company (2021-2026)
  4. 3.4 Global Menopausal Hot Flashes Drugs Average Price by Company (2021-2026)
  5. 3.5 Global Menopausal Hot Flashes Drugs Company Ranking (2024-2026)
  6. 3.6 Global Menopausal Hot Flashes Drugs Company Manufacturing Base and Headquarters
  7. 3.7 Global Menopausal Hot Flashes Drugs Company Product Type and Application
  8. 3.8 Global Menopausal Hot Flashes Drugs Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Menopausal Hot Flashes Drugs Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Menopausal Hot Flashes Drugs Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Menopausal Hot Flashes Drugs Market by Type
  1. 4.1 Menopausal Hot Flashes Drugs Type Introduction
  2. 4.1.1 Pill Menopausal Hot Flashes Drugs
  3. 4.1.2 Oral Liquid Menopausal Hot Flashes Drugs
  4. 4.1.3 Other
  5. 4.2 Global Menopausal Hot Flashes Drugs Sales Volume by Type
  6. 4.2.1 Global Menopausal Hot Flashes Drugs Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Menopausal Hot Flashes Drugs Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Menopausal Hot Flashes Drugs Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Menopausal Hot Flashes Drugs Sales Value by Type
  10. 4.3.1 Global Menopausal Hot Flashes Drugs Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Menopausal Hot Flashes Drugs Sales Value by Type (2021-2032)
  12. 4.3.3 Global Menopausal Hot Flashes Drugs Sales Value Share by Type (2021-2032)
5 Menopausal Hot Flashes Drugs Market by Application
  1. 5.1 Menopausal Hot Flashes Drugs Application Introduction
  2. 5.1.1 Retail Outlets
  3. 5.1.2 Online Stores
  4. 5.2 Global Menopausal Hot Flashes Drugs Sales Volume by Application
  5. 5.2.1 Global Menopausal Hot Flashes Drugs Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Menopausal Hot Flashes Drugs Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Menopausal Hot Flashes Drugs Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Menopausal Hot Flashes Drugs Sales Value by Application
  9. 5.3.1 Global Menopausal Hot Flashes Drugs Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Menopausal Hot Flashes Drugs Sales Value by Application (2021-2032)
  11. 5.3.3 Global Menopausal Hot Flashes Drugs Sales Value Share by Application (2021-2032)
6 Menopausal Hot Flashes Drugs Regional Sales and Value Analysis
  1. 6.1 Global Menopausal Hot Flashes Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Menopausal Hot Flashes Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Menopausal Hot Flashes Drugs Sales by Region: 2021-2026
  4. 6.2.2 Global Menopausal Hot Flashes Drugs Sales by Region (2027-2032)
  5. 6.3 Global Menopausal Hot Flashes Drugs Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Menopausal Hot Flashes Drugs Sales Value by Region (2021-2032)
  7. 6.4.1 Global Menopausal Hot Flashes Drugs Sales Value by Region: 2021-2026
  8. 6.4.2 Global Menopausal Hot Flashes Drugs Sales Value by Region (2027-2032)
  9. 6.5 Global Menopausal Hot Flashes Drugs Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Menopausal Hot Flashes Drugs Sales Value (2021-2032)
  12. 6.6.2 North America Menopausal Hot Flashes Drugs Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Menopausal Hot Flashes Drugs Sales Value (2021-2032)
  15. 6.7.2 Europe Menopausal Hot Flashes Drugs Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Menopausal Hot Flashes Drugs Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Menopausal Hot Flashes Drugs Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Menopausal Hot Flashes Drugs Sales Value (2021-2032)
  21. 6.9.2 South America Menopausal Hot Flashes Drugs Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Menopausal Hot Flashes Drugs Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Menopausal Hot Flashes Drugs Sales Value Share by Country, 2025 VS 2032
7 Menopausal Hot Flashes Drugs Country-level Sales and Value Analysis
  1. 7.1 Global Menopausal Hot Flashes Drugs Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Menopausal Hot Flashes Drugs Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Menopausal Hot Flashes Drugs Sales by Country (2021-2032)
  4. 7.3.1 Global Menopausal Hot Flashes Drugs Sales by Country (2021-2026)
  5. 7.3.2 Global Menopausal Hot Flashes Drugs Sales by Country (2027-2032)
  6. 7.4 Global Menopausal Hot Flashes Drugs Sales Value by Country (2021-2032)
  7. 7.4.1 Global Menopausal Hot Flashes Drugs Sales Value by Country (2021-2026)
  8. 7.4.2 Global Menopausal Hot Flashes Drugs Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Menopausal Hot Flashes Drugs Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Menopausal Hot Flashes Drugs Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Menopausal Hot Flashes Drugs Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Menopausal Hot Flashes Drugs Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Menopausal Hot Flashes Drugs Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Menopausal Hot Flashes Drugs Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Menopausal Hot Flashes Drugs Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Menopausal Hot Flashes Drugs Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Menopausal Hot Flashes Drugs Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Menopausal Hot Flashes Drugs Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Menopausal Hot Flashes Drugs Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Menopausal Hot Flashes Drugs Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Menopausal Hot Flashes Drugs Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Menopausal Hot Flashes Drugs Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Menopausal Hot Flashes Drugs Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Menopausal Hot Flashes Drugs Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Menopausal Hot Flashes Drugs Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Menopausal Hot Flashes Drugs Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Menopausal Hot Flashes Drugs Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Menopausal Hot Flashes Drugs Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Menopausal Hot Flashes Drugs Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Menopausal Hot Flashes Drugs Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Menopausal Hot Flashes Drugs Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Menopausal Hot Flashes Drugs Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Menopausal Hot Flashes Drugs Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Menopausal Hot Flashes Drugs Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Menopausal Hot Flashes Drugs Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Menopausal Hot Flashes Drugs Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Menopausal Hot Flashes Drugs Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Menopausal Hot Flashes Drugs Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Menopausal Hot Flashes Drugs Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Menopausal Hot Flashes Drugs Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Menopausal Hot Flashes Drugs Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Menopausal Hot Flashes Drugs Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Menopausal Hot Flashes Drugs Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Menopausal Hot Flashes Drugs Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Menopausal Hot Flashes Drugs Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Menopausal Hot Flashes Drugs Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Menopausal Hot Flashes Drugs Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Menopausal Hot Flashes Drugs Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Menopausal Hot Flashes Drugs Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Menopausal Hot Flashes Drugs Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Menopausal Hot Flashes Drugs Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Menopausal Hot Flashes Drugs Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Menopausal Hot Flashes Drugs Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Menopausal Hot Flashes Drugs Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Menopausal Hot Flashes Drugs Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Menopausal Hot Flashes Drugs Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Menopausal Hot Flashes Drugs Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Menopausal Hot Flashes Drugs Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Menopausal Hot Flashes Drugs Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Menopausal Hot Flashes Drugs Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Menopausal Hot Flashes Drugs Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Menopausal Hot Flashes Drugs Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Menopausal Hot Flashes Drugs Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Menopausal Hot Flashes Drugs Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Menopausal Hot Flashes Drugs Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Menopausal Hot Flashes Drugs Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Menopausal Hot Flashes Drugs Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Menopausal Hot Flashes Drugs Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Menopausal Hot Flashes Drugs Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Menopausal Hot Flashes Drugs Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Menopausal Hot Flashes Drugs Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Menopausal Hot Flashes Drugs Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Menopausal Hot Flashes Drugs Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Menopausal Hot Flashes Drugs Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Menopausal Hot Flashes Drugs Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Menopausal Hot Flashes Drugs Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Menopausal Hot Flashes Drugs Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Menopausal Hot Flashes Drugs Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Menopausal Hot Flashes Drugs Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Menopausal Hot Flashes Drugs Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Menopausal Hot Flashes Drugs Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Menopausal Hot Flashes Drugs Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Menopausal Hot Flashes Drugs Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Menopausal Hot Flashes Drugs Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Menopausal Hot Flashes Drugs Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Menopausal Hot Flashes Drugs Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Menopausal Hot Flashes Drugs Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Menopausal Hot Flashes Drugs Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Menopausal Hot Flashes Drugs Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Menopausal Hot Flashes Drugs Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Menopausal Hot Flashes Drugs Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Menopausal Hot Flashes Drugs Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Novartis
  2. 8.1.1 Novartis Company Information
  3. 8.1.2 Novartis Business Overview
  4. 8.1.3 Novartis Menopausal Hot Flashes Drugs Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Novartis Menopausal Hot Flashes Drugs Product Portfolio
  6. 8.1.5 Novartis Recent Developments
  7. 8.2 Pfizer
  8. 8.2.1 Pfizer Company Information
  9. 8.2.2 Pfizer Business Overview
  10. 8.2.3 Pfizer Menopausal Hot Flashes Drugs Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Pfizer Menopausal Hot Flashes Drugs Product Portfolio
  12. 8.2.5 Pfizer Recent Developments
  13. 8.3 Bayer
  14. 8.3.1 Bayer Company Information
  15. 8.3.2 Bayer Business Overview
  16. 8.3.3 Bayer Menopausal Hot Flashes Drugs Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Bayer Menopausal Hot Flashes Drugs Product Portfolio
  18. 8.3.5 Bayer Recent Developments
  19. 8.4 Novo Nordisk
  20. 8.4.1 Novo Nordisk Company Information
  21. 8.4.2 Novo Nordisk Business Overview
  22. 8.4.3 Novo Nordisk Menopausal Hot Flashes Drugs Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Novo Nordisk Menopausal Hot Flashes Drugs Product Portfolio
  24. 8.4.5 Novo Nordisk Recent Developments
  25. 8.5 iHealth Labs
  26. 8.5.1 iHealth Labs Company Information
  27. 8.5.2 iHealth Labs Business Overview
  28. 8.5.3 iHealth Labs Menopausal Hot Flashes Drugs Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 iHealth Labs Menopausal Hot Flashes Drugs Product Portfolio
  30. 8.5.5 iHealth Labs Recent Developments
  31. 8.6 Hisamitsu Pharmaceutical
  32. 8.6.1 Hisamitsu Pharmaceutical Company Information
  33. 8.6.2 Hisamitsu Pharmaceutical Business Overview
  34. 8.6.3 Hisamitsu Pharmaceutical Menopausal Hot Flashes Drugs Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Hisamitsu Pharmaceutical Menopausal Hot Flashes Drugs Product Portfolio
  36. 8.6.5 Hisamitsu Pharmaceutical Recent Developments
  37. 8.7 Allergan
  38. 8.7.1 Allergan Company Information
  39. 8.7.2 Allergan Business Overview
  40. 8.7.3 Allergan Menopausal Hot Flashes Drugs Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Allergan Menopausal Hot Flashes Drugs Product Portfolio
  42. 8.7.5 Allergan Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Menopausal Hot Flashes Drugs Value Chain Analysis
  2. 9.1.1 Menopausal Hot Flashes Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Menopausal Hot Flashes Drugs Sales Mode & Process
  6. 9.2 Menopausal Hot Flashes Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Menopausal Hot Flashes Drugs Distributors
  9. 9.2.3 Menopausal Hot Flashes Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst